ArticleJournal of medicinal chemistry2018

Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-Cells.

Jonathan Powell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.